US Patent 7135484 Azabicyclic compounds are central nervous system active agents
Patent 7135484 was granted and assigned to Abbott on November, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+39 characters)
Article
Patent abstract
Compounds of formula (I)
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07135484 Azabicyclic compounds are central nervous system active agents US Patent 7135484 Azabicyclic compounds are central nervous system active agents
Infobox
Patent Number
0713548400
Patent Number
713548400
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071354840
Date of Patent
November 14, 2006
0Patent Application Number
106383810
Date Filed
August 12, 2003
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071354840
Date of Patent
November 14, 2006
0Patent Application Number
106383810
Date Filed
August 12, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07135484 Azabicyclic compounds are central nervous system active agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07135484
Date of patent
November 14, 2006
Patent application number
10638381
Date Filed
August 12, 2003
Patent primary examiner
Find more entities like US Patent 7135484 Azabicyclic compounds are central nervous system active agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
